Industry › Healthcare & Pharm

Press Releases

兆科眼科的合作夥伴Vyluma發表用於治療兒童近視加深的NVK002之第III期CHAMP臨床試驗的正面研究結果

Oct 28, 2022 09:46 HKT/SGT

Zhaoke Ophthalmology's Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children

Oct 28, 2022 09:45 HKT/SGT

Avance Clinical贊助全球Scrip獎項的中國生物製藥獎

Oct 27, 2022 08:00 HKT/SGT

Avance Clinical赞助全球Scrip奖项的中国生物制药奖

Oct 27, 2022 08:00 HKT/SGT

중국에서의 임상 연구 기회와 미국 식품의약국 승인 경로 – 백서

Oct 27, 2022 07:00 HKT/SGT

Malaysian Genomics Signs Strategic Collaboration Agreement for Expansion in the UAE

Oct 26, 2022 19:00 HKT/SGT

云康集团（02325.HK）荣获香港股票分析师协会《上市公司年度大奖2022》

Oct 26, 2022 18:19 HKT/SGT

雲康集團（02325.HK）榮獲香港股票分析師協會《上市公司年度大奬2022》

Oct 26, 2022 18:18 HKT/SGT

中国的临床研究机会和美国食品药品监督管理局批准的途径 - 白皮书

Oct 26, 2022 07:00 HKT/SGT

中國的臨床研究機會和美國食品藥品監督管理局批准的途徑 - 白皮書

Oct 26, 2022 07:00 HKT/SGT

Clinical Research Opportunities in China and the Path to USFDA Approval - Whitepaper

Oct 25, 2022 18:00 HKT/SGT

Olympus Announces Leadership Succession Plan

Oct 21, 2022 14:00 HKT/SGT

Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round

Oct 20, 2022 14:45 HKT/SGT

생명공학 분야 웨비나: 시장 동향, 우선 순위, 예측 및 FDA 승인 경로

Oct 19, 2022 06:00 HKT/SGT

아쿠라바이오, 글로벌 성장 프로그램 추진을 위해 유능한 고위 경영진 임명

Oct 19, 2022 06:00 HKT/SGT

访中国抗体制药创办人梁瑞安：现是香港发展创科最好时候

Oct 18, 2022 13:30 HKT/SGT

訪中國抗體製藥創辦人梁瑞安：現是香港發展創科最好時候

Oct 18, 2022 13:29 HKT/SGT

AcuraBio、優秀なシニアエグゼクティブを任命　グローバル成長プログラムを推進

Oct 18, 2022 12:00 JST

AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program

Oct 18, 2022 07:00 HKT/SGT

生物技術領域網絡研討會：市場趨勢、優先事項、預測和 FDA 批准途徑

Oct 17, 2022 13:00 HKT/SGT